Sort by

Send to

Choose Destination

Links from PubMed

Items: 11


Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab.

Davis CC, Zelnak A, Eley JW, Goldstein DA, Switchenko JM, McKibbin T.

Ann Pharmacother. 2016 Sep;50(9):712-7. doi: 10.1177/1060028016654160. Epub 2016 Jun 15.


Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients.

Tian S, Hirshfield KM, Jabbour SK, Toppmeyer D, Haffty BG, Khan AJ, Goyal S.

Front Oncol. 2014 Oct 9;4:277. doi: 10.3389/fonc.2014.00277. eCollection 2014. Review.


Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors.

Onitilo AA, Engel JM, Stankowski RV.

Ther Adv Drug Saf. 2014 Aug;5(4):154-66. doi: 10.1177/2042098614529603. Review.


Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer.

Marinko T, Dolenc J, Bilban-Jakopin C.

Radiol Oncol. 2014 Apr 25;48(2):105-12. doi: 10.2478/raon-2013-0040. eCollection 2014 Jun. Review.


Radiotherapy and "new" drugs-new side effects?

Niyazi M, Maihoefer C, Krause M, Rödel C, Budach W, Belka C.

Radiat Oncol. 2011 Dec 21;6:177. doi: 10.1186/1748-717X-6-177. Review.


The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy.

Wood LM, Pan ZK, Seavey MM, Muthukumaran G, Paterson Y.

Cancer Immunol Immunother. 2012 May;61(5):689-700. doi: 10.1007/s00262-011-1129-9. Epub 2011 Nov 6.


Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice.

Yousif NG, Al-Amran FG.

BMC Cardiovasc Disord. 2011 Oct 14;11:62. doi: 10.1186/1471-2261-11-62.


Current neoadjuvant treatment options for HER2-positive breast cancer.

Abdel-Razeq H, Marei L.

Biologics. 2011;5:87-94. doi: 10.2147/BTT.S22917. Epub 2011 Aug 9.


Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.

Bishayee A, Ahmed S, Brankov N, Perloff M.

Front Biosci (Landmark Ed). 2011 Jan 1;16:980-96. Review.


Exercise therapy in the management of solid tumors.

Jones LW, Peppercom J, Scott JM, Battaglini C.

Curr Treat Options Oncol. 2010 Jun;11(1-2):45-58. doi: 10.1007/s11864-010-0121-5. Review. Corrected and republished in: Curr Treat Options Oncol. 2010 Dec;11(3-4):73-86.

Items per page

Supplemental Content

Write to the Help Desk